Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

155 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-07-31

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with chronic lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), who perform regular physical activity, have improved health and wellbeing compared with those who do little exercise. The purpose of the study is to evaluate whether the use of a simple pedometer (step counter) to set targets for daily physical activity can encourage COPD patients referred for an 8-week pulmonary exercise based programme (PR) to be more active. The investigators also want to know whether the use of pedometers during PR can improve adherence, self-management and outcome in COPD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of Internet Mediated Walking Program and Pedometer in COPD

NCT01772082

COPD

COMPLETED NA

Make Every Step Count: Personalised Music Feedback to Walking for People Living With COPD

NCT06629675

Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Lung Disease Chronic Obstructive Airway Disease

RECRUITING NA

Physical Activity Enhancement Using Pedometers in COPD

NCT01739751

COPD

UNKNOWN NA

Personalised Exercise Training in COPD

NCT03817294

COPD

COMPLETED NA

Use of the SMART COPD Physical Activity App in Pulmonary Rehabilitation

NCT02691104

Chronic Obstructive Pulmonary Disease (COPD)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Bronchitis, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

Standard 8-week pulmonary rehabilitation programme with 2 supervised sessions per week and a written home exercise plan/diary.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

Standard 8-week pulmonary rehabilitation programme with 2 supervised sessions per week. In addition they will receive a pedometer with a daily step count target set by a physiotherapist and a written home exercise plan/diary.

Group Type EXPERIMENTAL

Yamax Digi-Walker CW-700

Intervention Type DEVICE

A pedometer with a daily step count target set by a physiotherapist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Yamax Digi-Walker CW-700

A pedometer with a daily step count target set by a physiotherapist.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with COPD

Exclusion Criteria

* Any patient in whom mobility and lower limb function have been significantly affected by a neuromuscular disease, severe peripheral vascular disease or amputation
* Any patient whom the chief investigator feels it is unsafe to exercise (eg. unstable cardiac disease)

Eligible Sex

ALL

Accepts Healthy Volunteers

No